# Histaminergic Basis of Fatigue in Multiple Sclerosis

> **NCT04764383** · PHASE2 · WITHDRAWN · sponsor: **University of Miami**

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** L-Histidine
- **DRUG:** Placebo
- **DRUG:** Lodosyn

## Key facts

- **NCT ID:** NCT04764383
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-01
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn as more data drug analysis is recommended before the study.
- **Last updated:** 2021-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04764383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04764383, "Histaminergic Basis of Fatigue in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04764383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*